{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T01:46:10Z","timestamp":1785721570247,"version":"3.56.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejim.2026.106864","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T11:30:18Z","timestamp":1776079818000},"page":"106864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The paradox of increasing cardiac amyloidosis hospitalizations and persistent diagnostic delays"],"prefix":"10.1016","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-5076","authenticated-orcid":false,"given":"Artur","family":"Dziewierz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Susu\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Rajtar-Salwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2026.106864_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2026.106789","article-title":"Trends in cardiac amyloidosis hospital admissions and associated mortality risk over 20 years: a population-based study using healthcare administrative databases","author":"Ojeda-Fern\u00e1ndez","year":"2026","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.ejim.2026.106864_bib0002","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2025.10.021","article-title":"Delayed diagnosis of transthyretin amyloid cardiomyopathy in the veterans health administration","volume":"87","author":"Spencer-Bonilla","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ejim.2026.106864_bib0003","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacc.2025.09.004","article-title":"Transthyretin cardiac amyloidosis evaluation and management: 2025 ACC concise clinical guidance","volume":"87","author":"Kittleson","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2026.106864_bib0004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/ehaf710","article-title":"Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC heart failure association","volume":"47","author":"Garcia-Pavia","year":"2026","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.ejim.2026.106864_bib0005","doi-asserted-by":"crossref","first-page":"4785","DOI":"10.3390\/jcm14134785","article-title":"Transthyretin amyloid cardiomyopathy-2025 update: current diagnostic approaches and emerging therapeutic options","volume":"14","author":"Tsch\u00f6pe","year":"2025","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ejim.2026.106864_bib0006","first-page":"121","article-title":"Advancing treatments for transthyretin amyloid cardiomyopathy: innovations in RNA silencing, gene editing, TTR stabilization, and degradation","volume":"83","author":"Keller","year":"2025","journal-title":"Kardiol Pol"},{"issue":"1","key":"10.1016\/j.ejim.2026.106864_bib0007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5334\/gh.1275","article-title":"Standardising care and treatment of transthyretin amyloid cardiomyopathy","volume":"18","author":"Fontana","year":"2023","journal-title":"Glob Heart"},{"issue":"11","key":"10.1016\/j.ejim.2026.106864_bib0008","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.33963\/v.kp.97648","article-title":"Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: a position statement of the Polish Cardiac Society","volume":"81","author":"Grzybowski","year":"2023","journal-title":"Kardiol Pol"},{"issue":"1","key":"10.1016\/j.ejim.2026.106864_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.33963\/v.phj.110465","article-title":"From underrecognition to structured care: ATTR cardiac amyloidosis in Poland. Insights from a multicenter national cohort","volume":"84","author":"Tsch\u00f6pe","year":"2026","journal-title":"Kardiol Pol"},{"issue":"2","key":"10.1016\/j.ejim.2026.106864_bib0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jamacardio.2025.4591","article-title":"Detecting transthyretin cardiac amyloidosis with artificial intelligence: a nonrandomized clinical trial","volume":"11","author":"Jain","year":"2026","journal-title":"JAMA Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052600169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362052600169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T01:14:42Z","timestamp":1785719682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362052600169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":10,"alternative-id":["S095362052600169X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106864","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The paradox of increasing cardiac amyloidosis hospitalizations and persistent diagnostic delays","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2026.106864","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106864"}}